Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial
| Image |  |
|---|---|
| Description | scientific article published on 01 December 2014 |
| Author/s |
author: Judith R Kroep Harm van Tinteren |
| Publication date | December 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |